Here we gathered evidences showing that in SCLC, the innate immune response can be stimulated by altering the cGAS/STING pathway through micronuclei formation and/or cytoplasmastic DNA sensors regulation, transforming a cold tumour to a potential hot tumour, opening new opportunities for immunotherapy efficacy in SCLC. The gene discussed is CGAS; the disease is small cell lung carcinoma.